<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"canine":2,
"follicular carcinoma":1,
"gene expression":1,
"invasive":1,
"osteopontin":1,
"central compartment dissection (CCD)":1,
"papillary thyroid carcinoma (PTC)":2,
"posterior to right recurrent laryngeal nerve (PRRLN)":1,
"risk factors":2,
"hyperparathyroidism":2,
"parathyroid adenoma":1,
"parathyroidectomy":2,
"thyroid cancer":8,
"thyroidectomy":1,
"indigo carmine":1,
"localization":1,
"recurrence":1,
"ultrasound":3,
"Balloon":1,
"Cowden syndrome":3,
"PTEN":2,
"gastrointestinal stromal tumor (GIST)":1,
"hamartoma":1,
"small bowel":1,
"P antigen":1,
"erythrovirus":1,
"integrin α5β1":1,
"thyroid":9,
"Absorbed radiation dose":1,
"Adolescent idiopathic scoliosis":1,
"Brace treatment":1,
"Fluoroscopy":1,
"Radiation exposure":1,
"Treatment algorithm":1,
"Bethesda system":1,
"diagnostic accuracy":1,
"fine-needle aspiration, reporting system":1,
"calcitonin":1,
"medullary thyroid carcinoma":1,
"metastatic carcinoma":1,
"neuroendocrine carcinoma":1,
"parafollicular cell (C-cell)":1,
"paraganglioma":1,
"thyroid gland":4,
"Central neck":1,
"Lymph node dissection":1,
"Papillary thyroid carcinoma":3,
"Predictive factors":1,
"Subclinical lymph node metastasis":1,
"BRAF V600E mutation":1,
"Papillary thyroid cancer":3,
"pediatric":1,
"breast cancer":4,
"microcalcifications":1,
"sonography":2,
"thyroid metastasis":1,
"(131)I":1,
"Airborne radioactivity":1,
"Dose assessment":1,
"Population dose":1,
"MD Anderson Symptom Inventory":1,
"axitinib":2,
"metastatic disease":1,
"pharmacodynamic":1,
"pharmacokinetic":1,
"quality of life":1,
"radioactive iodine-refractory":1,
"tyrosine kinase inhibitor":1,
"Children":1,
"Small part":1,
"Elasticity score":1,
"Elastosonography":1,
"Strain ratio":1,
"Thyroid micronodules":1,
"Estrogen/GPER/ERK signaling":1,
"GPER":1,
"Targeted therapy":2,
"Triple-negative breast cancer":1,
"cytology":3,
"cytopathology":1,
"fine-needle aspiration":1,
"papillary hyperplasia":1,
"papillary lesions":1,
"I 131 induced sialoadenitis":1,
"Imaging in salivary diseases":1,
"Sialoendoscopy":1,
"human papillomavirus":1,
"p16":1,
"pRb":1,
"squamous cell carcinoma":1,
"survival":1,
"tonsil":1,
"18F-fluorodeoxyglucose uptake":1,
"extrathyroidal invasion":1,
"lymph node metastasis":1,
"papillary thyroid microcarcinoma":1,
"positron emission tomography/computed tomography":1,
"cancer":4,
"chemotherapy":1,
"comorbidities":1,
"febrile neutropenia":1,
"neutropenia":1,
"toxicity":1,
"cediranib":1,
"hypothyroidism":1,
"meta-analysis":1,
"sunitinib":1,
"Thyroid neoplasms":8,
"Ultrasonography":3,
"Cohort effect":1,
"Cáncer de tiroides":1,
"Efecto cohorte":1,
"Histology":1,
"Histología":1,
"Incidence":2,
"Incidencia":1,
"Tendencias":1,
"Thyroid neoplasm":2,
"Trends":1,
"Autoimmune diseases":1,
"Carcinoid tumor associated with paraneoplastic":1,
"Demyelinating disease (CNS)":1,
"Devic’s syndrome":1,
"Paraneoplastic syndrome":1,
"IMRT":1,
"chemoradiation":1,
"radiation therapy":1,
"High-frequency ultrasound":1,
"Non-Hodgkin's lymphoma":1,
"Primary":1,
"Thyroid tumor":2,
"Microcarcinoma":1,
"Taller-than-wide sign":1,
"EGF":1,
"ErbB receptors":1,
"Human thyroid carcinoma":1,
"TGF-β1":1,
"TβRII":1,
"BRAF":2,
"Key words:":1,
"MiRInform":1,
"RET/PTC":1,
"Ras":1,
"gene expression classifier":1,
"Anaplastic thyroid cancer":1,
"Myxoma virus":1,
"Oncolytic":1,
"Tanapox virus":1,
"Vaccinia virus":1,
"Angiogenesis":1,
"head and neck cancer":1,
"histopathology":1,
"lymphangiogenesis":1,
"Hyoidectomy":1,
"Hyperthyroidism":1,
"Radioactive iodine":1,
"Thyroid carcinoma":5,
"Remnant":1,
"Review":1,
"Thyroglossal duct":1,
"Apoptosis":1,
"Bcl-2":1,
"Caspase-3":1,
"P2X7R":1,
"miR-216b":1,
"hematological cancers":1,
"mammography":1,
"radiation":1,
"Acoustic radiation force impulse":1,
"Solid hypo-echoic thyroid nodule":1,
"Virtual Touch tissue imaging":1,
"Virtual Touch tissue quantification":1,
"old people":1,
"primary hyperparathyroidism":1,
"thyroid nodules":2,
"adenoid cystic carcinoma":2,
"cylindroma":1,
"long-term remission":1,
"age":1,
"childhood":1,
"pediatric type":1,
"prognosis":2,
"tall cell papillary carcinoma":1,
"therapy":2,
"iodine-refractory disease":1,
"multitargeted kinases":1,
"radioiodine therapy":3,
"isthmus":1,
"extracorporeal membrane oxygenation":1,
"fiberoptic bronchoscopy":1,
"tracheal tumor":1,
"cancer prevention":1,
"genetic cancer syndromes":1,
"risk management":1,
"Cancer thyroïdien différencié":1,
"Differentiated thyroid cancer":4,
"Recombinant human TSH":1,
"TSH humaine recombinante":1,
"Thyroglobulin":1,
"Thyroglobuline":1,
"Graves disease":1,
"Immune reconstitution":1,
"Infective thyroiditis":1,
"Inflammatory syndrome":1,
"Non-thyroidal illness":1,
"Thyroid function":1,
"131I scintigraphy":1,
"Salivary gland dysfunction":1,
"Salivary gland scintigraphy":1,
"Lung neoplasms":1,
"Metachronous":1,
"Second primary neoplasms":1,
"radioiodine fusion imaging":1,
"thyroid cancer staging and risk stratification":1,
"Cough":1,
"Desflurane":1,
"Propofol":1,
"Remifentanil":1,
"Sevoflurane":1,
"Akt":1,
"Anaplastic thyroid carcinoma":2,
"hsp70":1,
"hsp90":1,
"radicicol":1,
"paraptosis":1,
"tunicamycin":1,
"DUOX1":1,
"ROS":1,
"hepatocellular carcinoma":1,
"methylation":1,
"Diabetes mellitus":1,
"NHANES":1,
"Risk factor":1,
"POU transcription factor":1,
"neuroendocrine differentiation":1,
"proneural differentiation":1,
"small cell lung cancer":1,
"Ultrasonography, MRI":1,
"Arctic bear":1,
"insulinoma":1,
"islet amyloid polypeptide (IAPP)":1,
"Cordectomy":1,
"Estimation of voice":1,
"Glottic carcinoma":1,
"Sterno-thyroid muscle flap":1,
"chordektomia":1,
"ocena głosu":1,
"płat z mięśnia mostkowo-tarczowego":1,
"rak głośni":1,
"medullary thyroid cancer":1,
"multiple endocrine neoplasia":1,
"treatment":1,
"vandetanib":1,
"Carcinoma, Papillary":1,
"Lymphatic metastasis":1,
"Thyroglossal cyst":1,
"Biópsia por agulha fina":1,
"Fine needle biopsy":1,
"Glândula tireoide":1,
"Head and neck neoplasms":1,
"Neoplasias da glândula tireoide":1,
"Neoplasias de cabeça e pescoço":1,
"Targeted therapies":1,
"Diagnosis":2,
"Bilateral axillo-breast approach":1,
"Robot-assisted thyroidectomy":1,
"Robotic thyroidectomy":1,
"Transaxillary thyroidectomy":1,
"Sodium-iodide symporter":1,
"Target-specific therapy":1,
"Theranosis":1,
"Biopsy, fine-needle":1,
"Diagnostic errors":1,
"Neoplasm metastasis":2,
"Papillary":1,
"Sorafenib":1,
"Lymph nodes":1,
"Stomach neoplasms":1,
"Lung cancer":1,
"breast metastasis":1,
"immunohistochemistry":1,
"thyroid transcription factor-1 (TTF1)":1,
"percentage of BRAFV600E alleles":1,
"preoperative risk stratification":1,
"pyrosequencing":1,
"Brown tumor":1,
"ectopic parathyroid adenomas":1,
"humerus":1,
"Thymoma":2,
"ectopic":1,
"langerhans cell":1,
"micronodular":1,
"Ovarian teratoma":1,
"Struma ovary":1,
"Hashimoto":1,
"Thyroidits":1,
"Fine needle aspiration cytology":1,
"Follicular variant of papillary thyroid carcinoma":1,
"Papillary carcinoma thyroid":2,
"Secretory carcinoma breast":1,
"Antibodies":1,
"Anticuerpos":1,
"Cardiovascular":1,
"Cáncer":1,
"GLP-1":1,
"Gastrointestinal":1,
"Hipoglucemia":1,
"Hypoglycemia":1,
"Local reactions":1,
"Pancreatitis":1,
"Reacciones locales":1,
"Safety":1,
"Seguridad":1,
"Tiroides":1,
"Tolerability":1,
"Tolerancia":1,
"West Asia":1,
"diversity":1,
"mortality":1,
"Case-control study":1,
"Cuba":1,
"Epidemiology":1,
"Goiter":1,
"Mediastinal neoplasms":1,
"Myasthenia crisis":1,
"Substernal goiter":1,
"TTF-1":1,
"WHO classification":1,
"fine needle aspiration":1,
"gallbladder":1,
"neuroendocrine tumours":1,
"Mandible":1,
"metastasis":1,
"synchronous":1,
"FDG":1,
"PET-CT":1,
"incidentaloma":1,
"Carcinoma":1,
"Lung":1,
"Surfactant protein A":1,
"Thyroid transcription factor 1":1,
"Cytolyt":1,
"Molecular Testing":1,
"Thyroid fine-needle aspiration":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2014年9月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
